Home > Financial Ratios > VALIANT LABORATORIES

VALIANT LABORATORIES
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for VALIANT LABORATORIES
Please provide your vote to see the results

VALIANT LABORATORIES Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2025Mar2024Mar2023
   Core EBITDA Margin(%) -3.52-4.6210.50

What is the latest Core EBITDA Margin ratio of VALIANT LABORATORIES ?

The latest Core EBITDA Margin ratio of VALIANT LABORATORIES is -3.52 based on Mar2025 Consolidated results.
Year Core EBITDA Margin
Mar2025-3.52
Mar2024-4.62
Mar202310.50

How is Core EBITDA Margin of VALIANT LABORATORIES Trending?

Years Core EBITDA Margin % Change
Mar2025 -3.52
Negative
Mar2024 -4.62
Negative
Mar2023 10.5 -

Other Financial Ratios of VALIANT LABORATORIES


Compare Core EBITDA Margin ratio of peers of VALIANT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VALIANT LABORATORIES ₹354.6 Cr -4% -21.3% -35.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,248.0 Cr -0.2% 5.8% 0.9% Stock Analytics
DIVIS LABORATORIES ₹171,344.0 Cr -0.6% -5.2% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹125,832.0 Cr -0.5% 2.5% 12.1% Stock Analytics
CIPLA ₹121,820.0 Cr -1.1% -0.2% -1.2% Stock Analytics
DR REDDYS LABORATORIES ₹106,877.0 Cr 2.4% 7% 6.2% Stock Analytics


VALIANT LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VALIANT LABORATORIES

-4%

-21.3%

-35.2%

SENSEX

-0.6%

1.4%

7.7%


You may also like the below Video Courses